National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 34752 [2010-14771]

Download as PDF 34752 Federal Register / Vol. 75, No. 117 / Friday, June 18, 2010 / Notices onsite at White Oak Bldg. 1, 10903 New Hampshire Ave., Silver Spring, MD 20993. Presenters unable to appear onsite may submit a slide presentation to be shown during the Web-based public meeting. If possible, individuals and organizations with common interests should consolidate or coordinate their presentations and request time for a joint presentation. FDA will determine the amount of time allotted to each presenter and the approximate time that each oral presentation is scheduled to begin. FDA will contact each presenter prior to the Web-based public meeting with the amount of time available and the approximate time at which his or her presentation is scheduled to begin. Once FDA notifies presenters of their scheduled times, each presenter must submit to FDA an electronic copy of the presentation to be given. In order to be included in the Web-based public meeting, presentations must be received no later than June 25 at 5 P.M. (EDT). Please refer to FDA’s Web site (https:// www.fda.gov/Tobacco) for more information and updates on the Webbased public meeting. Transcripts of the Web-based public meeting will be available for review at the Division of Dockets Management (see ADDRESSES) and on the Internet at https:// www.regulations.gov approximately 30 days after the Web-based public meeting. IV. References srobinson on DSKHWCL6B1PROD with NOTICES The following references have been placed on display in the Division of Dockets Management (see ADDRESSES) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. (FDA has verified the Web site addresses, but we are not responsible for any subsequent changes to the Web sites after this document publishes in the Federal Register.) 1. Centers for Disease Control and Prevention, ‘‘Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 2000–2004,’’ Morbidity and Mortality Weekly Report (serial online); 57(45), pp. 1226–1228, 2008 (https://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5745a3.htm). 2. National Cancer Institute, U.S. Department of Health & Human Services, ‘‘The Role of the Media in Promoting and Reducing Tobacco Use,’’ Tobacco Control Monograph No. 19; p. 11, 2008 (https:// www.cancercontrol.cancer.gov/tcrb/ monographs/19/). 3. U.S. Department of Health and Human Services, ‘‘Tobacco Use Among U.S. Racial/ Ethnic Minority Groups—African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics,’’ A Report of the Surgeon General; VerDate Mar<15>2010 16:17 Jun 17, 2010 Jkt 220001 p. 220, 1998 (https://profiles.nlm.nih.gov/NN/ B/B/F/Q/_/nnbbfq.pdf). 4. Mitchell, O. and M. Greenberg, ‘‘Outdoor Advertising of Addictive Products,’’ New Jersey Medicine; 88, p. 331, 1991 (finding that billboards in Black and Hispanic neighborhoods in four New Jersey cities disproportionately contained advertisements for tobacco and alcohol products.) 5. Ammerman, S.D. and M. Nolden, ‘‘Neighborhood-Based Tobacco Advertising Targeting Adolescents,’’ Western Journal of Medicine; 162, pp. 514–518, 1995 (https:// www.ncbi.nlm.nih.gov/pmc/articles/ PMC1022829/pdf/westjmed00058–0028.pdf ) (finding that adolescent exposure to tobacco billboard advertisements in San Francisco in 1992 and 1993 was greater in Latino neighborhoods due to a greater adolescent population, and finding that qualitative analyses of the tobacco advertisements ‘‘suggested that adolescents are the primary targets.’’) 6. Stoddard, J.L., et. al., ‘‘Tailoring Outdoor Tobacco Advertising to Minorities in Los Angeles County,’’ Journal of Health Communication; 3. p. 137, 1998. 7. Primack, B.A., et al., ‘‘Volume of Tobacco Advertising in African American Markets: Systematic Review and MetaAnalysis,’’ Public Health Reports; 122, p. 607 2007. 8. National Cancer Institute, U.S. Department of Health and Human Services, ‘‘The Role of the Media in Promoting and Reducing Tobacco Use,’’ Tobacco Control Monograph No. 19; p. 57, 2008 (https:// www.cancercontrol.cancer.gov/tcrb/ monographs/19/). 9. Id., p. 15. Dated: June 15, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. [FR Doc. 2010–14809 Filed 6–14–10; 4:15 pm] would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Program Project Grant Review. Date: July 2, 2010. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Democracy Blvd, Suite 800, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Eric H. Brown, Scientific Review Officer, Scientific Review Branch, NIAMS/NIH, 6701 Democracy Blvd, Suite 824, Bethesda, MD 20892, (301) 594–4955, browneri@mail.nih.gov. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Clinical Trials Application Review. Date: July 16, 2010. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza—Dulles Airport, 2200 Centerville Road, Herndon, VA 20170. Contact Person: Michael L. Bloom, MBA, PhD, Scientific Review Officer, Scientific Review Branch, NIAMS/NIH, 6701 Democracy Blvd, Suite 820, Bethesda, MD 20892, 301–594–4953, bloomm2@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: June 14, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–14771 Filed 6–17–10; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Proposed Office of State, Tribal, Local and Territorial Support (OSTLTS) In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, the Centers for Disease Control and Prevention (CDC), OSTLTS announces the following Tribal Consultation Advisory Committee (TCAC) Meeting and Tribal Consultation Session: Name: Tribal Consultation Advisory Committee (TCAC) Meeting and 5th Biannual Tribal Consultation Session Times and Dates: TCAC Meeting on July 26–28, 2010, from 8 a.m.–6 p.m. and the 5th E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

[Federal Register Volume 75, Number 117 (Friday, June 18, 2010)]
[Notices]
[Page 34752]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-14771]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, Program 
Project Grant Review.
    Date: July 2, 2010.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Democracy Blvd, Suite 
800, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Eric H. Brown, Scientific Review Officer, 
Scientific Review Branch, NIAMS/NIH, 6701 Democracy Blvd, Suite 824, 
Bethesda, MD 20892, (301) 594-4955, browneri@mail.nih.gov.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, Clinical 
Trials Application Review.
    Date: July 16, 2010.
    Time: 8 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza--Dulles Airport, 2200 Centerville Road, 
Herndon, VA 20170.
    Contact Person: Michael L. Bloom, MBA, PhD, Scientific Review 
Officer, Scientific Review Branch, NIAMS/NIH, 6701 Democracy Blvd, 
Suite 820, Bethesda, MD 20892, 301-594-4953, bloomm2@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: June 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-14771 Filed 6-17-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.